SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending due to its robust earnings and optimistic outlook, confirming strong demand for AI and accelerated computing platforms. However, community discussion centers on the stock's muted price reaction despite the impressive results, with speculation ranging from market manipulation impacting options to ongoing debates about the sustainability of the AI boom versus an overvalued market.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Its shares are plummeting after Q1 revenue guidance fell short of analyst expectations despite a Q4 beat, fueling a community debate over whether the sell-off is an extreme overreaction to a minor miss or indicative of fundamental challenges and leadership concerns.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

A new $50 billion share buyback authorization is driving significant conversation around Salesforce, with investors sharply divided on whether it signals deep undervaluation and future EPS growth or a defensive maneuver against widespread AI disruption concerns in the software sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending with significant momentum following an impressive earnings blowout that exceeded expectations and strong 2026 revenue guidance, which is further bolstered by the company securing a spot on a major multi-billion dollar defense contract, prompting community discussion around a potential short squeeze.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is soaring after its Friedreich's ataxia treatment received FDA Breakthrough Therapy Designation, igniting strong investor optimism for accelerated approval and high valuations. However, an upsized public offering at $5.00 is simultaneously sparking intense debate among traders regarding dilution versus strategic funding for commercialization.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is surging after boosting its profit outlook and unveiling significant share buyback plans, exciting the community about its accelerated financial turnaround and strong growth prospects in civil aerospace, defense, and SMR-driven power systems.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is gaining attention ahead of its Q4 earnings, as investors anticipate strong results, profitability signals, and a potential short squeeze, fueled by the launch of new Sales Assist AI agents and strategic expansion into India, amplified by the positive sentiment from NVIDIA's broader AI narrative.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is seeing heightened attention ahead of its anticipated earnings report, with recent positive news around its Indensity battery architecture and a significant 400 MWh Texas battery project fueling discussion. The community is sharply divided on whether the company will deliver strong financials and guidance after past misses, while many highlight its long-term potential in the rapidly growing energy storage sector, especially in light of increasing power demands from AI data centers.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending on high anticipation for its imminent earnings report, fueled by optimistic projections for increased shelf space and Alani Nu's robust growth, though some in the community remain wary of past "noise" from management and speculate on a potential PepsiCo buyout strategy.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is seeing significant upward momentum following a strong Q4 earnings report that revealed substantial growth in USDC circulation and transaction volume. The community is actively discussing its potential as a core digital financial infrastructure for stablecoin transactions and AI agents, alongside short squeeze speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of "Hold" from Analysts

MacroGenics, Inc. (NASDAQ:MGNX - Get Free Report) has been given a consensus rating of "Hold" by the seven ratings firms that are covering the firm, Marketbeat reports. One investment analyst has...

MacroGenics (NASDAQ:MGNX) Stock Crosses Below 200-Day Moving Average - Should You Sell?

MacroGenics (NASDAQ:MGNX) Shares Pass Below 200 Day Moving Average - Here's What Happened...

MacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Hold" by Analysts

Shares of MacroGenics, Inc. (NASDAQ:MGNX - Get Free Report) have received an average recommendation of "Hold" from the seven ratings firms that are covering the firm, MarketBeat reports. One equities...

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes

SNY wins EU approval for Teizeild, the first disease-modifying drug to delay stage 3 type 1 diabetes in adults and children aged eight and older.

MacroGenics (NASDAQ:MGNX) Stock Price Crosses Above 50 Day Moving Average - What's Next?

MacroGenics (NASDAQ:MGNX) Shares Cross Above 50-Day Moving Average - Here's What Happened...

FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children

Sanofi wins FDA priority review to expand Tzield's use to children as young as one, aiming to delay type 1 diabetes progression.

MacroGenics (NASDAQ:MGNX) Rating Lowered to "Hold" at Zacks Research

Zacks Research cut shares of MacroGenics from a "strong-buy" rating to a "hold" rating in a research note on Thursday...

MacroGenics (NASDAQ:MGNX) Shares Pass Above 50 Day Moving Average - Should You Sell?

MacroGenics (NASDAQ:MGNX) Stock Price Crosses Above Fifty Day Moving Average - Should You Sell...

MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of MacroGenics, Inc. (NASDAQ:MGNX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven brokerages that are covering the firm, Marketbeat reports. One equities...

EcoR1 Capital LLC Purchases New Shares in MacroGenics, Inc. $MGNX

EcoR1 Capital LLC acquired a new stake in MacroGenics, Inc. (NASDAQ:MGNX - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor...

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.06	--	--	N/A
Q3 '25	-$0.45	$0.27	160.60%	BEAT
Q2 '25	-$0.42	-$0.57	-34.65%	MISSED
Q1 '25	-$0.73	-$0.65	10.43%	BEAT
Q4 '24	-$0.28	-$0.24	13.90%	BEAT

MGNX
Macrogenics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MGNX News

MGNXMacrogenics Inc